A Systematic Review of Wearable Sensors in Rett Syndrome—What Physiological Markers Are Informative for Monitoring Disease States?
Open Access
Abstract
Rett syndrome (RTT) presents with a wide range of symptoms spanning various clinical areas. Capturing symptom change as the disorder progresses is challenging. Wearable sensors offer a non-invasive and objective means of monitoring disease states in neurodevelopmental disorders. The goal of this study was to conduct a systematic literature review to critically appraise the literature on the use of wearable sensors in individuals with RTT. The PRISMA criteria were used to search four databases without time restriction and identified 226 records. After removing duplicates, the titles and abstracts of 184 records were screened, 147 were excluded, and 37 were assessed for eligibility. Ten (10) articles remained, and a further two were included after additional searching. In total, 12 articles were included in the final analysis. The sample size ranged from 7 to 47 subjects with an age range of 1 to 41 years. Different wearable biosensor devices were used across studies, with the Empatica E4 wearable device being most frequently used in 33% (4/12) of the studies. All the studies demonstrated a high methodological quality with a low risk of bias. Evidence from wearable sensors, combined with machine learning methods, enabled the prediction of different sleep patterns and clinical severity in RTT. Given the small sample size and the limitations of available data for training machine learning models, we highlight areas for consideration. The review emphasises the need to enhance research on the application of wearable sensors in epilepsy and gastrointestinal manifestations/morbidity in RTT. Increased electrodermal activity (EDA), % of maximum heart rate (HRmax%) and the heart rate to low-frequency power (HR/LF) ratio were identified as physiological measures potentially associated with disease states. Based on the evidence synthesis, the role of physiological parameters and their association with symptom management in RTT is discussed.Keywords
This publication has 86 references indexed in Scilit:
- Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental DisordersJAMA Psychiatry, 2025
- Towards automatic assessment of atypical early motor development?Brain Research Bulletin, 2025
- Heart rate deceleration capacity as a marker of perioperative risk: identifying relevant patient phenotypes and surgical proceduresBritish Journal of Anaesthesia, 2024
- Biochemical and molecular determinants of the subclinical inflammatory mechanisms in Rett syndromeArchives of Biochemistry and Biophysics, 2024
- Potential for heart rate deceleration capacity in assessing perioperative autonomic function and predicting adverse cardiovascular eventsBritish Journal of Anaesthesia, 2024
- Development and validation of a machine learning‐based tool to predict autism among childrenAutism Research, 2023
- Repurposing fluvoxamine, and other psychiatric medications, for COVID‐19 and other conditionsWorld Psychiatry, 2022
- Prediction of Autism Risk From Family Medical History Data Using Machine Learning: A National Cohort Study From DenmarkBiological Psychiatry Global Open Science, 2021
- Quality of life related to clinical features in patients with Rett syndrome and their parents: a systematic reviewMetabolic Brain Disease, 2018
- Wearable sensors for clinical applications in epilepsy, Parkinson’s disease, and stroke: a mixed-methods systematic reviewJournal of Neurology, 2018